13F filing recap · Q4 2022

What did Bill & Melinda Gates Foundation Trust buy in Q4 2022?

Reported stock-position changes between this filing and the previous one.

Stock value

$35.73B

Positions

Estimated turnover

5.1%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

New positions

HRLHormel Foods Corporation$100.00Mreported value+2.20M shares DHRDanaher Corporation$99.00Mreported value+373.0K shares

Increased positions

ECLEcolab Inc.$759.54Mreported value+351.6K shares+7.2%

Reduced positions

BRK.BBerkshire Hathaway Inc$7.63Breported value-5.00M shares-16.8%